By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sound Pharmaceuticals, Inc. 

4010 Stone Way, N Suite 120

Seattle  Washington  98103  U.S.A.
Phone: 206-634-2559 Fax: 206-634-2342



Company News
Sound Pharmaceuticals, Inc. Completes Enrollment On Meniere's Disease Clinical Trial 6/27/2017 8:45:38 AM
Sound Pharmaceuticals, Inc. Announces $1.6 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Prevent And Treat The Hearing Loss And Tinnitus Associated With Antibiotic Use 3/21/2017 7:51:11 AM
Sound Pharmaceuticals, Inc. Announces Two New Executive Hires To Accelerate Its Meniere's Drug Development Program 11/1/2016 8:42:28 AM
Sound Pharmaceuticals, Inc. And DoD Collaborate On New Hearing Loss Guidance 9/7/2016 9:52:57 AM
Sound Pharmaceuticals, Inc. To Present At The 15th Annual Needham & Company Healthcare Conference 4/4/2016 10:10:29 AM
Sound Pharmaceuticals, Inc. Announces Appointment Of Paul Rickey As Chief Financial Officer 3/16/2016 7:50:22 AM
Sound Pharmaceuticals, Inc. And University of Oxford Collaborate On A New Treatment For Bipolar Disorder 3/9/2016 7:23:19 AM
FDA Allows Sound Pharmaceuticals, Inc. To Begin Meniere's Disease Clinical Trial 1/5/2016 7:37:20 AM
Sound Pharmaceuticals, Inc. Submits Positive Phase 2 Clinical Trial Data On SPI-1005 For The Prevention And Treatment Of Sensorineural Hearing Loss 2/18/2014 7:09:50 AM
Sound Pharmaceuticals, Inc. Successfully Completes Its First Phase 2 Clinical Trial With SPI-1005 Involving iPod® or Noise Induced Hearing Loss 11/5/2013 9:43:00 AM